The landscape of diabetes care is evolving with the emergence of transdermal GLP-1 delivery . These convenient delivery systems offer a possibly more comfortable alternative to injections for individuals dealing with type 2 diabetes . They deliver a GLP-1 agonist directly through the skin , circu